• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板参数与 2019 年冠状病毒病患者死亡率的相关性:回顾性队列研究。

Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study.

机构信息

Intensive Care Unit, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, China.

Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, China.

出版信息

Platelets. 2020 May 18;31(4):490-496. doi: 10.1080/09537104.2020.1754383. Epub 2020 Apr 16.

DOI:10.1080/09537104.2020.1754383
PMID:32297540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7171387/
Abstract

BACKGROUND

Thrombocytopenia has been implicated in patients infected with severe acute respiratory syndrome coronavirus 2, while the association of platelet count and changes with subsequent mortality remains unclear.

METHODS

The clinical and laboratory data of 383 patients with the definite outcome by March 1, 2020 in the Central Hospital of Wuhan were reviewed. The association between platelet parameters and mortality risk was estimated by utilizing Cox proportional hazard regression models.

RESULTS

Among the 383 patients, 334 (87.2%) were discharged and survived, and 49 (12.8%) died. Thrombocytopenia at admission was associated with mortality of almost three times as high as that for those without thrombocytopenia ( < 0.05). Cox regression analyses revealed that platelet count was an independent risk factor associated with in-hospital mortality in a dose-dependent manner. An increment of per 50 × 10/L in platelets was associated with a 40% decrease in mortality (hazard ratio: 0.60, 95%CI: 0.43, 0.84). Dynamic changes of platelets were also closely related to death during hospitalization.

CONCLUSIONS

Baseline platelet levels and changes were associated with subsequent mortality. Monitoring platelets during hospitalization may be important in the prognosis of patients with coronavirus disease in 2019.

摘要

背景

血小板减少与严重急性呼吸综合征冠状病毒 2 感染的患者有关,而血小板计数的变化与随后的死亡率之间的关系尚不清楚。

方法

回顾了 2020 年 3 月 1 日前在武汉市中心医院明确结局的 383 例患者的临床和实验室数据。利用 Cox 比例风险回归模型评估血小板参数与死亡风险的相关性。

结果

在 383 例患者中,334 例(87.2%)出院并存活,49 例(12.8%)死亡。入院时的血小板减少症与死亡率几乎高出三倍,与无血小板减少症的患者相比(<0.05)。Cox 回归分析显示,血小板计数是与住院死亡率相关的独立危险因素,呈剂量依赖性。血小板每增加 50×10/L,死亡率降低 40%(危险比:0.60,95%CI:0.43,0.84)。血小板的动态变化也与住院期间的死亡密切相关。

结论

基线血小板水平和变化与随后的死亡率有关。住院期间监测血小板可能对 2019 年冠状病毒病患者的预后很重要。

相似文献

1
Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study.血小板参数与 2019 年冠状病毒病患者死亡率的相关性:回顾性队列研究。
Platelets. 2020 May 18;31(4):490-496. doi: 10.1080/09537104.2020.1754383. Epub 2020 Apr 16.
2
Thrombocytopenia and its association with mortality in patients with COVID-19.血小板减少症及其与 COVID-19 患者死亡率的关系。
J Thromb Haemost. 2020 Jun;18(6):1469-1472. doi: 10.1111/jth.14848. Epub 2020 May 4.
3
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病(COVID-19)感染相关:一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
4
Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.与 COVID-19 患者血小板减少症发展相关的机制。
Thromb Res. 2020 Sep;193:110-115. doi: 10.1016/j.thromres.2020.06.008. Epub 2020 Jun 5.
5
Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.新型冠状病毒肺炎患者止血实验室检查异常特征分析,重点关注血小板计数。
Platelets. 2020 Aug 17;31(6):740-745. doi: 10.1080/09537104.2020.1768523. Epub 2020 May 26.
6
Platelets in Coronavirus Disease 2019.2019冠状病毒病中的血小板
Semin Thromb Hemost. 2020 Oct;46(7):823-825. doi: 10.1055/s-0040-1710006. Epub 2020 Apr 30.
7
Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值预测 2019 年冠状病毒病(COVID-19)住院患者的全因死亡率:单中心回顾性队列研究。
Epidemiol Infect. 2020 Sep 9;148:e211. doi: 10.1017/S0950268820002071.
8
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.空腹血糖受损和糖尿病与 2019 冠状病毒病患者的并发症和死亡率升高相关。
Front Endocrinol (Lausanne). 2020 Jul 10;11:525. doi: 10.3389/fendo.2020.00525. eCollection 2020.
9
Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts.马萨诸塞州东部住院的 2019 年冠状病毒病患者中严重疾病和死亡相关的实验室检查结果。
JAMA Netw Open. 2020 Oct 1;3(10):e2023934. doi: 10.1001/jamanetworkopen.2020.23934.
10
A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.用于预测 COVID-19 合并实体瘤患者死亡率的列线图:一项多中心回顾性队列研究。
J Immunother Cancer. 2020 Sep;8(2). doi: 10.1136/jitc-2020-001314.

引用本文的文献

1
Effect of COVID-19 on hematological parameters and subsequent risk of anemia and bleeding in middle-aged and elderly patients with type 2 diabetes.2019冠状病毒病对中老年2型糖尿病患者血液学参数及后续贫血和出血风险的影响
J Family Med Prim Care. 2025 Jul;14(7):2974-2979. doi: 10.4103/jfmpc.jfmpc_5_25. Epub 2025 Jul 21.
2
Red Cell Distribution Width (RDW), Platelets and Platelet Index MPV/PLT Ratio as Specific Time Point Predictive Variables of Survival Outcomes in COVID-19 Hospitalized Patients.红细胞分布宽度(RDW)、血小板及血小板指数MPV/PLT比值作为COVID-19住院患者生存结局的特定时间点预测变量
J Clin Med. 2025 Jul 30;14(15):5381. doi: 10.3390/jcm14155381.
3
Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection.研究急性SARS-CoV-2感染期间SARS-CoV-2病毒血症与外周炎症在血小板功能障碍中的相互作用。
Pathog Immun. 2025 Jul 9;10(2):149-167. doi: 10.20411/pai.v10i2.823. eCollection 2025.
4
Comparison of Platelet Indices, Lymphocyte, and Systemic Inflammation Indices on Days 1 and 8 in Surviving and Non-Surviving COVID-19 Patients at Hasan Sadikin General Hospital, Bandung, Indonesia.印度尼西亚万隆哈桑·萨迪金综合医院新冠病毒疾病(COVID-19)存活与非存活患者第1天和第8天血小板指标、淋巴细胞及全身炎症指标的比较
J Blood Med. 2025 Feb 4;16:61-74. doi: 10.2147/JBM.S499023. eCollection 2025.
5
Utility of Hematological and Biochemical Parameters as a Screening Tool for Assessing Coronavirus Disease 2019 Infection and its Severity.血液学和生化参数作为评估2019冠状病毒病感染及其严重程度的筛查工具的效用
J Microsc Ultrastruct. 2023 Jan 19;12(4):214-220. doi: 10.4103/jmau.jmau_59_22. eCollection 2024 Oct-Dec.
6
Laboratory findings predictive of critical illness in hospitalized COVID-19 patients in Tunisia.突尼斯住院COVID-19患者中预测危重症的实验室检查结果。
F1000Res. 2024 Nov 18;13:918. doi: 10.12688/f1000research.151333.2. eCollection 2024.
7
Outcomes of Cancer Patients Affected by COVID-19 in Different Settings: A Retrospective Study in Lebanon.不同环境下 COVID-19 对癌症患者的影响结果:黎巴嫩的一项回顾性研究。
Cancer Rep (Hoboken). 2024 Nov;7(11):e70045. doi: 10.1002/cnr2.70045.
8
A Retrospective Study: Evaluating the Impact of the COVID-19 Pandemic on Inflammatory Markers in Hospitalized Patients.一项回顾性研究:评估新冠疫情对住院患者炎症标志物的影响
Infect Dis Rep. 2024 Aug 14;16(4):735-749. doi: 10.3390/idr16040056.
9
Exploring the relationship between blood platelet and other components utilizing count regression: A cross-sectional study in Bangladesh.利用计数回归探索血小板与其他成分之间的关系:孟加拉国的一项横断面研究。
Health Sci Rep. 2024 Aug 20;7(8):e70007. doi: 10.1002/hsr2.70007. eCollection 2024 Aug.
10
A Comparative Analysis of Laboratory Parameters of Hospitalized COVID-19 Patients by Disease Severity and Mortality at a Facility in Ibadan, Nigeria.尼日利亚伊巴丹一家医疗机构中按疾病严重程度和死亡率对住院COVID-19患者实验室参数的比较分析
Niger Med J. 2023 May 11;64(2):243-250. eCollection 2023 Mar-Apr.

本文引用的文献

1
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病(COVID-19)感染相关:一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
4
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
5
Journey of a Thai Taxi Driver and Novel Coronavirus.一位泰国出租车司机与新型冠状病毒的历程
N Engl J Med. 2020 Mar 12;382(11):1067-1068. doi: 10.1056/NEJMc2001621. Epub 2020 Feb 12.
6
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
7
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
8
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.德国一名无症状接触者传播2019新型冠状病毒感染
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.
9
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
10
The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors.肺是血小板生物发生的场所,也是造血祖细胞的储存库。
Nature. 2017 Apr 6;544(7648):105-109. doi: 10.1038/nature21706. Epub 2017 Mar 22.